2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T49d,This study included 19 743 patients with CISDs; 1877 were SGM patients (median age, 40.5 years [IQR, 28.7-57.9 years]; 1205 [64.2%] assigned female sex at birth) and 17 866 were non-SGM patients (median age, 57.1 years [IQR, 40.8-68.1 years]; 13 205 [73.9%] assigned female sex at birth). Compared with non-SGM patients, SGM patients with CISDs were significantly more likely to delay specialist care (adjusted odds ratio [AOR], 1.23; 95% CI, 1.03-1.47), mental health care (AOR, 1.62; 95% CI, 1.37-1.91), and filling a prescription (AOR, 1.30; 95% CI, 1.11-1.52) because of cost. In addition, SGM patients with CISDs were significantly more likely than non-SGM patients to delay care because of transportation issues (AOR, 1.49; 95% CI, 1.22-1.80) and not having a health care practitioner who shares the same background with regard to race and ethnicity, religion, native language, sexual orientation, and gender identity (AOR, 1.39; 95% CI, 1.19-1.62). Sexual and gender minority patients with CISDs were also significantly more likely than non-SGM patients to report not always being treated with respect by their health care practitioners (AOR, 1.47; 95% CI, 1.30-1.65).31:Ta63,Research on the prevalence of barriers to care among sexual and gender minority (SGM) patients with chronic inflammatory skin diseases (CISDs) in the US is limited. To compare the prevalence of cost and noncost barriers to care among SGM and non-SGM patients with CISDs and to analyze the prevalence of barriers based on SGM status and race and ethnicity. A cross-sectional study of health care access and utilization survey data collected by the National Institutes of Health's All of Us Research Program between May 31, 2017, and July 1, 2022, was conducted. Participants were adults aged 18 years or older with CISDs who enrolled in All of Us directly online or through partner health care practitioner organizations located across the US. Chronic inflammatory skin diseases, sexual orientation and gender identity, and race and ethnicity. The main outcome was the experience of cost and noncost barriers to health care among SGM patients with CISDs. Multivariable logistic regression was used to examine the association of SGM status with experiencing barriers to care. This study included 19 743 patients with CISDs; 1877 were SGM patients (median age, 40.5 years [IQR, 28.7-57.9 years]; 1205 [64.2%] assigned female sex at birth) and 17 866 were non-SGM patients (median age, 57.1 years [IQR, 40.8-68.1 years]; 13 205 [73.9%] assigned female sex at birth). Compared with non-SGM patients, SGM patients with CISDs were significantly more likely to delay specialist care (adjusted odds ratio [AOR], 1.23; 95% CI, 1.03-1.47), mental health care (AOR, 1.62; 95% CI, 1.37-1.91), and filling a prescription (AOR, 1.30; 95% CI, 1.11-1.52) because of cost. In addition, SGM patients with CISDs were significantly more likely than non-SGM patients to delay care because of transportation issues (AOR, 1.49; 95% CI, 1.22-1.80) and not having a health care practitioner who shares the same background with regard to race and ethnicity, religion, native language, sexual orientation, and gender identity (AOR, 1.39; 95% CI, 1.19-1.62). Sexual and gender minority patients with CISDs were also significantly more likely than non-SGM patients to report not always being treated with respect by their health care practitioners (AOR, 1.47; 95% CI, 1.30-1.65). The findings of this cross-sectional study of survey data suggest that SGM patients with CISDs may be disproportionately affected by cost and noncost barriers to health care. Dermatologists and other health care practitioners caring for SGM patients with CISDs have an important role in helping to address these barriers and larger systemic issues for SGM patients at both the patient and system levels.32:Td1b,ImportanceResearch on the prevalence of barriers to care among sexual and gender minority (SGM) patients with chronic inflammatory skin diseases (CISDs) in the US is limited.ObjectiveTo compare the prevalence of cost and noncost barriers to care among SGM and non-SGM patients with CISDs and to analyze the prevalence of barriers based on SGM status and race and ethnicity.Design, Setting, and ParticipantsA cross-sectional study of health care access and utilization survey data collected by the National Institutes of Health’s All of Us Research Program between May 31, 2017, and July 1, 2022, was conducted. Participants were adults aged 18 years or older with CISDs who enrolled in All of Us directly online or through partner health care practitioner organizations located across the US.ExposuresChronic inflammatory skin diseases, sexual orientation and gender identity, and race and ethnicity.Main Outcome and MeasuresThe main outcome was the experience of cost and noncost barriers to health care among SGM patients with CISDs. Multivariable logistic regression was used to examine the association of SGM status with experiencing barriers to care.ResultsThis study included 19 743 patients with CISDs; 1877 were SGM patients (median age, 40.5 years [IQR, 28.7-57.9 years]; 1205 [64.2%] assigned female sex at birth) and 17 866 were non-SGM patients (median age, 57.1 years [IQR, 40.8-68.1 years]; 13 205 [73.9%] assigned female sex at birth). Compared with non-SGM patients, SGM patients with CISDs were significantly more likely to delay specialist care (adjusted odds ratio [AOR], 1.23; 95% CI, 1.03-1.47), mental health care (AOR, 1.62; 95% CI, 1.37-1.91), and filling a prescription (AOR, 1.30; 95% CI, 1.11-1.52) because of cost. In addition, SGM patients with CISDs were significantly more likely than non-SGM patients to delay care because of transportation issues (AOR, 1.49; 95% CI, 1.22-1.80) and not having a health care practitioner who shares the same background with regard to race and ethnicity, religion, native language, sexual orientation, and gender identity (AOR, 1.39; 95% CI, 1.19-1.62). Sexual and gender minority patients with CISDs were also significantly more likely than non-SGM patients to report not always being treated with respect by their health care practitioners (AOR, 1.47; 95% CI, 1.30-1.65).Conclusions and RelevanceThe findings of this cross-sectional study of survey data suggest that SGM patients with CISDs may be disproportionately affected by cost and noncost barriers to health care. Dermatologists and other health care practitioners caring for SGM patients with CISDs have an important role in helping to address these barriers and larger systemic issues for SGM patients at both the patient and system levels.25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Chronic Inflammatory Skin Disease: condition Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on Chronic Inflammatory Skin Disease (condition). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/condition/Chronic%20Inflammatory%20Skin%20Disease\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Conditions\",\"item\":\"https://www.reachrx.ai/hub/tag/condition\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Chronic Inflammatory Skin Disease\",\"item\":\"https://www.reachrx.ai/hub/tag/condition/Chronic%20Inflammatory%20Skin%20Disease\"}]}}"}}]],["$","$L2f",null,{"title":"Chronic Inflammatory Skin Disease: Research & Clinical Takeaways","description":"Discover peer-reviewed research on Chronic Inflammatory Skin Disease with concise clinician summaries and next-step guidance.","papers":[{"doi":"10.1001/jamadermatol.2023.3328","pmid":"37755822","title":"Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases in the US","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2023-09-27T00:00:00.000Z","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10535014","source_score":121,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2023-12-23","doi":"10.1001/jamadermatol.2023.3328","days":"30","issn":"2168-6068","rank":"2","field":"Clinical Medicine","score":"121","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2023.3328","title":"Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases in the US.","journal":"JAMA dermatology","methods":"","results":"$30","abstract":"$31","keywords":[],"pubmed_id":"37755822","conclusions":"","publication_date":"2023-09-27T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2023.3328","URL":"https://doi.org/10.1001/jamadermatol.2023.3328","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2809654/jamadermatology_nock_2023_oi_230045_1701809849.26216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"1323","type":"journal-article","issue":"12","score":1,"title":["Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases in the US"],"author":[{"given":"Michael R.","family":"Nock","sequence":"first","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut"}]},{"given":"Kanika","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts"}]},{"given":"John G.","family":"Zampella","sequence":"additional","affiliation":[{"name":"Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York, New York"}]},{"given":"Mya L.","family":"Roberson","sequence":"additional","affiliation":[{"name":"Gillings School of Global Public Health, University of North Carolina at Chapel Hill"}]},{"given":"Jeffrey M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Boston, Massachusetts"}]}],"issued":{"date-parts":[[2023,12,1]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"159","created":{"date-time":"2023-09-27T15:34:50Z","timestamp":1695828890000,"date-parts":[[2023,9,27]]},"indexed":{"date-time":"2025-09-17T15:24:43Z","timestamp":1758122683752,"date-parts":[[2025,9,17]]},"subject":[],"abstract":"$32","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2809654"}},"subtitle":[],"deposited":{"date-time":"2023-12-20T16:04:34Z","timestamp":1703088274000,"date-parts":[[2023,12,20]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2023,12,1]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.2105/AJPH.2016.303049","key":"doi230045r1","year":"2016","issue":"6","author":"Dahlhamer","volume":"106","first-page":"1116","unstructured":null,"article-title":"Barriers to health care among adults identifying as sexual minorities: a US national study.","journal-title":"Am J Public Health","doi-asserted-by":"publisher"},{"DOI":"10.2105/AJPH.2020.305598","key":"doi230045r2","year":"2020","issue":"6","author":"Hernandez","volume":"110","first-page":"857","unstructured":null,"article-title":"Barriers to health care among adults with minoritized identities in the United States, 2013-2017.","journal-title":"Am J Public Health","doi-asserted-by":"publisher"},{"DOI":"10.1056/NEJMsr1809937","key":"doi230045r3","year":"2019","issue":"7","author":"Denny","volume":"381","first-page":"668","unstructured":null,"article-title":"The “All of Us” Research Program.","journal-title":"N Engl J Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.09.054","key":"doi230045r4","year":"2023","issue":"3","author":"Nock","volume":"88","first-page":"568","unstructured":null,"article-title":"Racial and ethnic differences in barriers to care among US adults with chronic inflammatory skin diseases: A cross-sectional study of the All of Us Research Program.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11606-021-06737-1","key":"doi230045r6","year":"2021","issue":"10","author":"Sharma","volume":"36","first-page":"3179","unstructured":null,"article-title":"A Consensus-Based Checklist for Reporting of Survey Studies (CROSS).","journal-title":"J Gen Intern Med","doi-asserted-by":"publisher"},{"DOI":"10.1086/669608","key":"doi230045r8","year":"2013","issue":"4","author":"Cho","volume":"38","first-page":"785","unstructured":null,"article-title":"Toward a field of intersectionality studies: theory, applications, and praxis.","journal-title":"Signs (Chic Ill)","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamanetworkopen.2021.3789","key":"doi230045r9","year":"2021","issue":"3","author":"Salsberg","volume":"4","first-page":null,"unstructured":null,"article-title":"Estimation and comparison of current and future racial/ethnic representation in the US health care workforce.","journal-title":"JAMA Netw Open","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2021.4544","key":"doi230045r10","year":"2021","issue":"12","author":"Mansh","volume":"157","first-page":"1512","unstructured":null,"article-title":"Lesbian, gay, bisexual, and transgender identity and disclosure among dermatologists in the US.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2015.10.044","key":"doi230045r11","year":"2016","issue":"3","author":"Pandya","volume":"74","first-page":"584","unstructured":null,"article-title":"Increasing racial and ethnic diversity in dermatology: a call to action.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2022.4984","key":"doi230045r13","year":"2023","issue":"1","author":"Gao","volume":"159","first-page":"47","unstructured":null,"article-title":"Diversity and career goals of graduating allopathic medical students pursuing careers in dermatology.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.v38.s2","key":"doi230045r14","year":"2021","issue":null,"author":"Covelli","volume":"38","first-page":"65","unstructured":null,"article-title":"Influence of gender and sexual identity on adolescent skin health.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamanetworkopen.2020.24583","key":"doi230045r15","year":"2020","issue":"11","author":"Takeshita","volume":"3","first-page":null,"unstructured":null,"article-title":"Association of racial/ethnic and gender concordance between patients and physicians with patient experience ratings.","journal-title":"JAMA Netw Open","doi-asserted-by":"publisher"},{"DOI":"10.1001/archinte.159.9.997","key":"doi230045r16","year":"1999","issue":"9","author":"Saha","volume":"159","first-page":"997","unstructured":null,"article-title":"Patient-physician racial concordance and the perceived quality and use of health care.","journal-title":"Arch Intern Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2017.01.039","key":"doi230045r17","year":"2017","issue":"6","author":"Adamson","volume":"76","first-page":"1193","unstructured":null,"article-title":"Patient-provider race and sex concordance and the risk for medication primary nonadherence.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2019.2063","key":"doi230045r18","year":"2019","issue":"10","author":"Gorbatenko-Roth","volume":"155","first-page":"1129","unstructured":null,"article-title":"Assessment of Black patients’ perception of their dermatology care.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2020.0113","key":"doi230045r19","year":"2020","issue":"5","author":"Jia","volume":"156","first-page":"593","unstructured":null,"article-title":"Sexual and gender minority curricula within US dermatology residency programs.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.03.008","key":"doi230045r20","year":"2022","issue":null,"author":"Gomez","volume":null,"first-page":null,"unstructured":null,"article-title":"Hidradenitis suppurativa in sexual and gender minorities: A review and considerations for providers.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2018.02.042","key":"doi230045r21","year":"2019","issue":"3","author":"Yeung","volume":"80","first-page":"581","unstructured":null,"article-title":"Dermatologic care for lesbian, gay, bisexual, and transgender persons: terminology, demographics, health disparities, and approaches to care.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2020.0112","key":"doi230045r22","year":"2020","issue":"5","author":"Sternhell-Blackwell","volume":"156","first-page":"497","unstructured":null,"article-title":"Residency education on sexual and gender minority health: ensuring culturally competent dermatologists and excellent patient care.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2018.3909","key":"doi230045r23","year":"2019","issue":"2","author":"Mansh","volume":"155","first-page":"145","unstructured":null,"article-title":"Improving dermatologic care for sexual and gender minority patients through routine sexual orientation and gender identity data collection.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jdin.2020.10.010","key":"doi230045r24","year":"2020","issue":null,"author":"Barbieri","volume":"2","first-page":"31","unstructured":null,"article-title":"Use of primary care services among patients with chronic skin disease seen by dermatologists.","journal-title":"JAAD Int","doi-asserted-by":"publisher"},{"DOI":"10.1111/hesr.v54.s2","key":"doi230045r25","year":"2019","issue":"Suppl 2","author":"Casey","volume":"54","first-page":"1454","unstructured":null,"article-title":"Discrimination in the United States: Experiences of lesbian, gay, bisexual, transgender, and queer Americans.","journal-title":"Health Serv Res","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.amepre.2020.12.022","key":"doi230045r26","year":"2021","issue":"6","author":"English","volume":"60","first-page":"781","unstructured":null,"article-title":"Intersecting structural oppression and Black sexual minority men’s health.","journal-title":"Am J Prev Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0140-6736(17)30569-X","key":"doi230045r27","year":"2017","issue":"10077","author":"Bailey","volume":"389","first-page":"1453","unstructured":null,"article-title":"Structural racism and health inequities in the USA: evidence and interventions.","journal-title":"Lancet","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2017.1130","key":"doi230045r28","year":"2017","issue":"8","author":"Song","volume":"153","first-page":"755","unstructured":null,"article-title":"Medicare Part D payments for topical steroids: rising costs and potential savings.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.06.1164","key":"doi230045r29","year":"2023","issue":"2","author":"Patel","volume":"88","first-page":"490","unstructured":null,"article-title":"A retrospective claims analysis confirms the cost of most biologic agents for psoriasis is increasing more rapidly than medical inflation.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.v36.5","key":"doi230045r30","year":"2019","issue":"5","author":"Boos","volume":"36","first-page":"581","unstructured":null,"article-title":"Dermatologic care of sexual and gender minority/LGBTQIA youth, part I: an update for the dermatologist on providing inclusive care.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.v36.5","key":"doi230045r31","year":"2019","issue":"5","author":"Kosche","volume":"36","first-page":"587","unstructured":null,"article-title":"Dermatologic care of sexual and gender minority/LGBTQIA youth, part 2: recognition and management of the unique dermatologic needs of SGM adolescents.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2018.02.045","key":"doi230045r32","year":"2019","issue":"3","author":"Yeung","volume":"80","first-page":"591","unstructured":null,"article-title":"Dermatologic care for lesbian, gay, bisexual, and transgender persons: epidemiology, screening, and disease prevention.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi230045r5","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"All of Us Research Program. Who can join? National Institutes of Health. Accessed January 30, 2023. https://www.joinallofus.org/who-can-join","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230045r7","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Center for Intersectional Justice. What is intersectionality. Accessed June 21, 2023. https://www.intersectionaljustice.org/what-is-intersectionality","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230045r12","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Jones? JM. LGBT identification rises to 5.6% in latest US estimate. Gallup. February 24, 2021. Accessed December 24, 2022. https://news.gallup.com/poll/329708/lgbt-identification-rises-latest-estimate.aspx","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"published-print":{"date-parts":[[2023,12,1]]},"reference-count":32,"published-online":null,"references-count":32,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":12},"unpaywall":{"doi":"10.1001/jamadermatol.2023.3328","is_oa":true,"title":"Barriers to Care Among Sexual and Gender Minority Individuals With Chronic Inflammatory Skin Diseases in the US","updated":"2025-07-30T00:59:52+00:00","published_date":"2023-09-27","best_oa_location":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10535014","pmh_id":"oai:pubmedcentral.nih.gov:10535014","url_for_pdf":null,"url_for_landing_page":"https://www.ncbi.nlm.nih.gov/pmc/articles/10535014"}}},"created_at":"2025-09-20T17:25:21.471Z","updated_at":"2025-09-20T17:37:44.075Z","tags":[{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"condition","value":"Chronic Inflammatory Skin Disease","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"level_of_evidence","value":"5","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"sample_size","value":"n=19,743","value_numeric":19743},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"study_design","value":"Cross-Sectional Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"warning","value":"Adjusted odds ratios are reported; absolute prevalence by SGM status is not provided in the excerpt.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"warning","value":"Cross-sectional design—associations cannot establish causality.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.3328","tag_type":"warning","value":"Some small cell counts were suppressed (≤20), so exact numbers are not available for all subgroups.","value_numeric":null}],"summaries":{"what_studied":"A US cross-sectional analysis (May 31, 2017–July 1, 2022) of adults ≥18 years in the All of Us program with chronic inflammatory skin diseases compared sexual and gender minority (SGM) vs non‑SGM patients on cost and noncost barriers to care using multivariable logistic regression.","key_result":"Among 19,743 patients (SGM 1,877; non‑SGM 17,866), SGM patients had higher adjusted odds of delaying specialist care (AOR 1.23; 95% CI 1.03-1.47), mental health care (AOR 1.62; 95% CI 1.37-1.91), and filling a prescription (AOR 1.30; 95% CI 1.11-1.52) due to cost; and higher odds of delaying care due to transportation (AOR 1.49; 95% CI 1.22-1.80) and because providers were from different backgrounds (AOR 1.39; 95% CI 1.19-1.62). They were also more likely to report not always being treated with respect (AOR 1.47; 95% CI 1.30-1.65).","limitations":"Cross-sectional survey data preclude causal inference; some associations attenuated after adjusting for socioeconomic factors (e.g., delaying general doctor visit lost significance); small cell sizes (1–20) were suppressed per policy, limiting detail.","practice_takeaway":"Expect more cost- and transport-related delays and perceived disrespect among SGM patients with chronic inflammatory skin diseases; proactively ask about affordability, prescription costs, transportation, and provider fit, and address these barriers within clinic workflows."}}],"initialOffset":1,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"condition","value":"Chronic Inflammatory Skin Disease"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Conditions","href":"/hub/tag/condition"},{"name":"Chronic Inflammatory Skin Disease"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"condition","hub_tag_value":"Chronic Inflammatory Skin Disease"}}}]]

Papers